Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition

被引:179
作者
ter Brake, Olivier [1 ]
't Hooft, Karen [1 ]
Liu, Ying Poi [1 ]
Centlivre, Mireille [1 ]
von Eije, Karin Jasmijn [1 ]
Berkhout, Ben [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immunity Amsterdam CINIMA, Dept Med Microbiol,Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1038/sj.mt.6300382
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Human immunodeficiency virus type 1 ( HIV- 1) replication in T cells can be inhibited by RNA interference ( RNAi) through short hairpin RNA ( shRNA) expression from a lentiviral vector. However, for the development of a durable RNAi- based gene therapy against HIV- 1, multiple shRNAs need to be expressed simultaneously in order to avoid viral escape. In this study, we tested a multiple shRNA expression strategy for different shRNAs using repeated promoters in a lentiviral vector. Although highly effective in co- transfection experiments, a markedly reduced activity of each expressed shRNA was observed in transduced cells. We found that this reduced activity was due to recombination of the expression cassette repeat sequences during the transduction of the lentiviral vector, which resulted in deletions of one or multiple cassettes. To avoid recombination, we tested different promoters for multiple shRNA expression. We compared the activity of the human polymerase III promoters U6, H1, and 7SK and the polymerase II U1 promoter. Activities of these promoters were similar, irrespective of which shRNA was expressed. We showed that these four expression cassettes can be combined in a single lentiviral vector without causing recombination. Moreover, whereas HIV- 1 could escape from a single shRNA, we now show that HIV- 1 escape can be prevented when four shRNAs are simultaneously expressed in a cell.
引用
收藏
页码:557 / 564
页数:8
相关论文
共 50 条
[1]   Frequency of direct repeat deletion in a human immunodeficiency virus type 1 vector during reverse transcription in human cells [J].
An, WF ;
Telesnitsky, A .
VIROLOGY, 2001, 286 (02) :475-482
[2]   Safety and efficacy of a lentiviral vector containing three anti-HIV genes - CCR5 ribozyme, tat-rev siRNA, and TAR decoy - in SCID-hu mouse-derived T cells [J].
Anderson, Joseph ;
Li, Ming-Jie ;
Palmer, Brent ;
Remling, Leila ;
Li, Shirley ;
Yam, Priscilla ;
Yee, Jiing-Kuan ;
Rossi, John ;
Zaia, John ;
Akkina, Ramesh .
MOLECULAR THERAPY, 2007, 15 (06) :1182-1188
[3]   HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector [J].
Anderson J. ;
Akkina R. .
AIDS Research and Therapy, 2 (1)
[4]   HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-γc-/- (RAG-hu) mouse model [J].
Berges, Bradford K. ;
Wheat, William H. ;
Palmer, Brent E. ;
Connick, Elizabeth ;
Akkina, Ramesh .
RETROVIROLOGY, 2006, 3 (1)
[5]  
Berkhout B, 2004, CURR OPIN MOL THER, V6, P141
[6]   The interplay between virus infection and the cellular RNA interference machinery [J].
Berkhout, Ben ;
Haasnoot, Joost .
FEBS LETTERS, 2006, 580 (12) :2896-2902
[7]   Inhibition of respiratory viruses by nasally administered siRNA [J].
Bitko, V ;
Musiyenko, A ;
Shulyayeva, O ;
Barik, S .
NATURE MEDICINE, 2005, 11 (01) :50-55
[8]   Human immunodeficiency virus type 1 escape from RNA interference [J].
Boden, D ;
Pusch, O ;
Lee, F ;
Tucker, L ;
Ramratnam, B .
JOURNAL OF VIROLOGY, 2003, 77 (21) :11531-11535
[9]   Promoter choice affects the potency of HIV-1 specific RNA interference [J].
Boden, D ;
Pusch, O ;
Lee, F ;
Tucker, L ;
Shank, PR ;
Ramratnam, B .
NUCLEIC ACIDS RESEARCH, 2003, 31 (17) :5033-5038
[10]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553